摘要
Background Galectin-3 is a new cytokine that is mainly secreted by activated macrophages. It is involved in apoptosis, inflammation and may play a role in the development of cardiovascular disease (CVD). However, there is little information about the association between circulating galectin-3 and subclinical atherosclerosis in humans. @@@ Methods and results We measured serum galectin-3 in 483 obese adult subjects (aged 40 years and over) who had the measurement of carotid intima-media thickness (CIMT) recruited from the community. Adults with lower levels of circulating galectin-3 had increased CIMT (p < 0.05). In multivariable linear regression analyses, circulating galectin-3 was independently associated with CIMT. The risks of increased CIMT were significantly decreased by 65.1% (OR (95% CI): 0.349 (0.165-0.739)), adjusting for possible confounding factors. Notably, individuals in the lowest quartile of serum galectin-3 were 1.80 times (p < 0.05) more likely to have increased CIMT than those in the highest quartile in multivariable logistic regression analyses; however, such associations with circulating galectin-3 were not noted for carotid plague. @@@ Conclusions These findings propose that circulating galectin-3 concentrations are inversely associated with increased CIMT in obese adults, which may be a potential biomarker of CVD.
学科与关键词
- Association Between Serum Galectin-3 Levels and Coronary Stenosis Severity in Patients With Coronary Artery DiseaseLi, Mingxing; Guo, Kai; Huang, Xuansheng; Feng, Li; Yuan, Yong; Li, Jiewen; Lao, Yi; Guo, Zhigang*Frontiers in Cardiovascular Medicine, 2022, 9: 818162.被引 9
- Circulating adipsin is associated with asymptomatic carotid atherosclerosis in obese adultsZhang, Jinhua; Teng, Fei; Pan, Lingling; Guo, Dan; Liu, Jianfang; Li, Kangli; Yuan, Youwen; Li, Wenyuan*; Zhang, Huijie*BMC Cardiovascular Disorders, 2021, 21(1): 517.被引 2
- Prognostic Value of Serum Galectin-3 in Chronic Heart Failure: A Meta-AnalysisCheng, Zhendong; Cai, Kefeng; Xu, Chaoxian; Zhan, Qiong; Xu, Xingbo; Xu, Dingli*; Zeng, Qingchun*Frontiers in Cardiovascular Medicine, 2022, 9: 783707.被引 5
